Literature DB >> 2307684

The effects of foreign transmembrane domains on the biosynthesis of the influenza virus hemagglutinin.

J Lazarovits1, S P Shia, N Ktistakis, M S Lee, C Bird, M G Roth.   

Abstract

Eleven chimeric proteins were created in which the transmembrane, the cytoplasmic, or both topological domains of the influenza virus hemagglutinin (HA) were replaced with those from five other glycoproteins. All of the chimeric HAs reached the cell surface but appeared to differ in the degree to which they were stably folded. Comparisons of the rates of folding, passage into the Golgi, and arrival at the plasma membrane of wild-type HA and the chimeric proteins suggest that formation of a stable HA trimer is not an absolute requirement for export from the endoplasmic reticulum. In addition, there appear to be at least two steps at which the rate of transport can be altered during exocytosis, one occurring before and the other after the trimming of oligosaccharides by Golgi mannosidases. Certain of the chimeras differed from HA in their ability to pass through each of these steps. Replacement of the HA transmembrane domain with the analogous sequences from other proteins affected folding and transport of the chimeric HAs in ways that suggest that the HA transmembrane sequences form a specific structure in the membrane that differs from that formed by analogous sequences from the other proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307684

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly.

Authors:  C S Robison; M A Whitt
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.

Authors:  G B Melikyan; S Lin; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

3.  A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.

Authors:  J Dong; M G Roth; E Hunter
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Effects of altering palmitylation sites on biosynthesis and function of the influenza virus hemagglutinin.

Authors:  H Y Naim; B Amarneh; N T Ktistakis; M G Roth
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  The Rous sarcoma virus Env glycoprotein contains a highly conserved motif homologous to tyrosine-based endocytosis signals and displays an unusual internalization phenotype.

Authors:  C Ochsenbauer; S R Dubay; E Hunter
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

6.  Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain.

Authors:  P Scheiffele; M G Roth; K Simons
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

7.  Effects of deletions in the carboxy-terminal hydrophobic region of herpes simplex virus glycoprotein gB on intracellular transport and membrane anchoring.

Authors:  L Rasile; K Ghosh; K Raviprakash; H P Ghosh
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Basis for selective incorporation of glycoproteins into the influenza virus envelope.

Authors:  H Y Naim; M G Roth
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

9.  Phospholipase D is present on Golgi-enriched membranes and its activation by ADP ribosylation factor is sensitive to brefeldin A.

Authors:  N T Ktistakis; H A Brown; P C Sternweis; M G Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  A fluorescent lipid analogue can be used to monitor secretory activity and for isolation of mammalian secretion mutants.

Authors:  N T Ktistakis; C Y Kao; R H Wang; M G Roth
Journal:  Mol Biol Cell       Date:  1995-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.